Verapamil 40mg tablets

Country: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ixtrih issa

Ingredjent attiv:

Verapamil hydrochloride

Disponibbli minn:

Mawdsley-Brooks & Company Ltd

Kodiċi ATC:

C08DA01

INN (Isem Internazzjonali):

Verapamil hydrochloride

Dożaġġ:

40mg

Għamla farmaċewtika:

Oral tablet

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 02060200

Fuljett ta 'informazzjoni

                                PACKAGE LEAFLET:INFORMATION FOR THE USER
VERAPAMIL 40 MG, 80 MG AND
120 MG TABLETS
verapamil hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your
doctor or pharmacist.
-
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
-
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
1. What Verapamil is and what it is used for
2. What you need to know before you take
Verapamil
3. How to take Verapamil
4. Possible side effects
5. How to store Verapamil
6. Contents of the pack and other information
WHAT VERAPAMIL IS AND WHAT IT IS USED FOR
Verapamil is a calcium channel blocker, which
expands your blood vessels to allow more blood
to flow through them. It also acts on the nerve
signals passing through the heart muscle, which
can help to correct certain types of abnormal
heart rhythm.
Verapamil is used:
-
to prevent or treat angina (chest pain) and
certain abnormal heart rhythms
-
to treat high blood pressure.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE
VERAPAMIL
DO NOT TAKE VERAPAMIL
-
if you are allergic to Verapamil or any of the
other ingredients of this medicine (listed in
section 6).
-
if you have a very slow heart-beat of less than
50 beats per minute.
-
if you suffer from heart problems including sick
sinus syndrome (causing a slow heart rate).
-
if you suffer Lown-Ganong-Levine or
Wolff-Parkinson-White syndrome (causing
palpitations).
-
if you have had a heart attack which has been
followed by a slow heart rate, low blood
pressure or breathlessness.
-
if you have very low blood pressure due to
heart problems.
-
if you have a WEAK HEART (causing
breathlessness and tiredness).
-
if you have problems of conduction in the heart
such as sino atrial block and
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
VERAPAMIL TABLETS BP 40mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 40mg Verapamil Hydrochloride PhEur.
Excipient with known effect
Sunset yellow aluminium lake (E110)
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Yellow film-coated tablets.
Yellow, circular, biconvex film-coated tablets, impressed “C” on
one face and the
identifying letters “VR” on the reverse. Tablet diameter:
6.18-6.82mm.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
1) The management of mild to moderate hypertension and renal
hypertension, used alone or
in combination with other antihypertensive therapy (see section 4.3
for warning regarding
concomitant administration with beta-blockers).
2) For the management and prophylaxis of angina pectoris (including
variant angina).
3) The treatment and prophylaxis of paroxysmal supraventricular
tachycardia and the
reduction of the ventricular rate in atrial fibrillation/flutter.
Verapamil should not be used
for atrial fibrillation/flutter in patients with Wolff-Parkinson-White
syndrome (see section
4.4).
_4.2 _
_POSOLOGY AND METHOD OF ADMINISTRATION _
Posology
_Adults: _
_Hypertension:_ 240mg verapamil daily. For patients new to verapamil
therapy, the physician
should consider halving the initial dose to 120mg. Most patients
respond to 240mg daily
given as a single dose. If control is not achieved after a period of
at least one week, the
dosage may be increased to a maximum of 480mg (in divided doses of
240mg in the
morning and 240mg in the evening, at an interval of about twelve
hours). A further
reduction in blood pressure may be acheived by combining verapamil
with other
antihypertensive agents, in particular diuretics. 120mg may be used
for dose titration
purposes. _ _
_Angina pectoris:_ 120mg twice daily. A small number of patients
respond to a lower dose
and where indictaed, adjustment down to 120mg daily could be made.
120mg may be used
for dose titration purposes.
_ _
_
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott